Comparison of Bare metal Vs Drug eluting stents for in-stent Restenosis among Diabetics
Background: Diabetes mellitus is associated with an increased risk of restenosis, stent thrombosis, and death afterpercutaneous coronary interventions. Little is known about the late outcome of patients with diabetes mellitus whoreceive drug-eluting stents (DES) or bare metal stents (BMS).Methods: F...
Main Authors: | Kakhaber Etsadashvili, Khatuna Jalabadze, Georgi Getmansky, Irakli Davitashvili, Ia Avaliani, Mynuddin Ahmed Nawaz |
---|---|
Format: | Article |
Language: | English |
Published: |
Electronic Physician
2011-06-01
|
Series: | Electronic Physician |
Subjects: | |
Online Access: | http://ephysician.ir/2011/409-413.pdf |
Similar Items
-
Caracterización de la restenosis de stents coronarios convencionales y liberadores de medicamentos en pacientes incluidos en el registro DRug Eluting STent (DREST) Characterization of conventional coronary stents restenosis and drug eluting stents in patients included in the Drug Eluting Stent Registry (DREST)
by: Jorge A Arroyave C, et al.
Published: (2012-06-01) -
Natural history of coronary stents: 14 year follow-up of drug eluting stents versus bare metal stents
by: Rohit Sunil Walse, et al.
Published: (2023-11-01) -
Comparison between a Bare–Metal Stents and Drug Eluting Stents in patients undergoing Percutaneous Coronary Intervention.
by: Khaled Alsayed
Published: (2020-10-01) -
Effect of a Drug-Eluting Stent vs. Bare Metal Stent for the Treatment of Symptomatic Intracranial and Vertebral Artery Stenosis
by: Jiang-Hua Si, et al.
Published: (2022-07-01) -
Do pre-procedural laboratory parameters predict drug-eluting stent restenosis?
by: Aslı Tanındı, et al.
Published: (2015-07-01)